ABSTRACT The aim of the present study was to determine if the measurement of the slope of the histamine dose-response curve (bronchial reactivity) could provide useful information on 
index than reactivity in characterising the clinical state of asthmatics.
Bronchial reactions to inhaled non-allergic agents such as histamine and acetylcholine derivatives are characterised mainly by the dose required to produce a fixed change in a functional measurement. When FEV1 is the functional index used, a 20 % change is generally judged as significant in reflecting bronchial hyperexcitability.1 The provocative concentration producing a 20% change in FEV1 (PC2oFEV1) has thus been proposed to quantify the reaction. 2 Orehek and Gayrard3 have suggested that inhalation dose-response curves should be studied in a pharmacological manner in which distinction is made between sensitivity (the dose at which reaction is initiated) and reactivity (the slope of the doseresponse curve beyond this point). who either were in a steady clinical state or showed alterations in their condition.
Methods
Fifteen adult asthmatic subjects were studied (nine men and six women) whose age ranged from 18 to 52 years (mean = 33-7; SD = 12-3, table). All subjects met the criteria for the definition of asthma proposed by the American Thoracic Society.5 In addition, all subjects had previously shown, either spontaneously or after inhaled bronchodilator, a variation in FEV1 of 20% or more. Skin prick tests were done with a routine battery of 15 common inhaled antigens extracts. Atopy was considered to be present whenever a patient had two or more immediate positive skin reactions. Eleven subjects were found to be atopic. On their first visit, all these patients were in a clinical steady state and 11 of them had been included in another study. 6 At that time, they reported no exacerbation of asthma in the previous two months and no recent respiratory infection. On the 731 unsteady clinical state. There was a significant relationship between PC20FEV1 and the initial FEV1 (r = 0 42, p < 0.02) and this is also in keeping with previous findings2 1619 20 which relate airways hyperexcitability with the initiaJ airways obstruction. In a previous report,6 the correlation coefficient between PC2oFEV1 assessed with the Dosimeter and the initial FEV1 (expressed in percentage of the predicted value) was 0-36. This result is slightly less than the correlation coefficient of 0-42 found in the present study. This discrepancy may be explained by the fact that the two investigations did not include exactly the same subjects (only 11 of the total of 24 patients were common to the two studies).
One of the six patients who experienced changes in symptoms and need for medication demonstrated changes in FEVI which were less than 10 % from one visit to the other. This patient (9) The second item for discussion in the analysis of the dose-response curve is the threshold point. Orehek and his colleagues15 suggested that the threshold should be a change of 15 % in FEV1 when this measurement is used. This threshold point appears to us rather arbitrary. We indeed showed that linear curves can be drawn by using points below the 15 % limit. Fifteen per cent is well above the intrasubject reproducibility of the FEV1. We think that for each subject, changes of FEV, which were beyond two standard deviations of the six postdiluent measurements should reasonably be included in the individual curve. This opinion has also been expressed by others.2' Another point which seems important is the upper limit of changes in FEVy which should be included in the dose-response curve. The maximal change in FEV, obtained for each subject and at each visit should be similar so that curves are analysed within the same range of changes of FEV1.
Although we observed that clinical state as defined in our study by symptomatology, drug requirement, and changes in FEV1 does not influence reactivity, the influence of other factors such as time of day when the test is performed, previous drug administration, and inhalation of pollutants has yet to be determined.
